{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:29:18Z","timestamp":1793917758465,"version":"4.8.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372661"],"award-info":[{"award-number":["82372661"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.154368","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:41:59Z","timestamp":1788882119000},"page":"154368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["A lipoprotein-responsive circular RNA, circCTCF, couples extracellular lipid availability to mTOR signaling via ACSL5 in triple-negative breast cancer"],"prefix":"10.1016","volume":"382","author":[{"given":"Yuanyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Shicao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick F.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.154368_bb0005","doi-asserted-by":"crossref","unstructured":"Anders CK, Carey LA: Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin. Breast Cancer 2009, 9 Suppl 2(Suppl 2):S73\u201381.","DOI":"10.3816\/CBC.2009.s.008"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.154368_bb0015","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1200\/JCO.2010.34.5579","article-title":"TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer","volume":"30","author":"Carey","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154368_bb0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clbc.2016.05.006","article-title":"Panitumumab, gemcitabine, and carboplatin as treatment for women with metastatic triple-negative breast Cancer: a Sarah Cannon research institute phase II trial","volume":"16","author":"Yardley","year":"2016","journal-title":"Clin. Breast Cancer"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154368_bb0025","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/annonc\/mdw665","article-title":"Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer","volume":"28","author":"Bell","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0030","doi-asserted-by":"crossref","unstructured":"Xun X, Ai J, Feng F, Hong P, Rai S, Liu R, Zhang B, Zhou Y, Hu H: Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: a meta-analysis. Front. Pharmacol. 2023, 14:1108772.","DOI":"10.3389\/fphar.2023.1108772"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154368_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast Cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.154368_bb0040","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with Pembrolizumab in early-stage triple-negative breast Cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0045","doi-asserted-by":"crossref","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ: Metabolic reprogramming and cancer progression. Science 2020, 368(6487).","DOI":"10.1126\/science.aaw5473"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154368_bb0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","article-title":"The metabolism of cancer cells during metastasis","volume":"21","author":"Bergers","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of Cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/112_2020_51","article-title":"Lipid droplets in Cancer","volume":"185","author":"Petan","year":"2023","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41423-026-01411-0","article-title":"Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment","volume":"23","author":"Du","year":"2026","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12944-024-02212-y","article-title":"Roles of lipid droplets and related proteins in metabolic diseases","volume":"23","author":"Zhang","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41420-023-01493-z","article-title":"Lipid droplets: a cellular organelle vital in cancer cells","volume":"9","author":"Jin","year":"2023","journal-title":"Cell Death Discov."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154368_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23081941","article-title":"Lipid droplets in Cancer: guardians of fat in a stressful world","volume":"23","author":"Petan","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0085","doi-asserted-by":"crossref","unstructured":"Joshi S, Garlapati C, Pradhan A, Gandhi K, Balogun A, Aneja R: Lipid droplets in cancer: new insights and therapeutic potential. Int. J. Mol. Sci. 2026, 27(2).","DOI":"10.3390\/ijms27020918"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154368_bb0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat. Metab."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154368_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050389","article-title":"Cholesterol trafficking: an emerging therapeutic target for angiogenesis and Cancer","volume":"8","author":"Lyu","year":"2019","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154368_bb0100","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","article-title":"Plasma lipoproteins: apolipoprotein structure and function","volume":"25","author":"Mahley","year":"1984","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154368_bb0105","article-title":"Lipid metabolism and breast Cancer: a narrative review of the prognostic implications and chemotherapy-induced dyslipidemia","volume":"15","author":"Faur","year":"2025","journal-title":"Life (Basel)"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154368_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8060853","article-title":"HDL and LDL: potential new players in breast Cancer development","volume":"8","author":"Cedo","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0115","doi-asserted-by":"crossref","unstructured":"Rodrigues Dos Santos C, Fonseca I, Dias S, Mendes de Almeida JC: Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression. BMC Cancer 2014, 14:132.","DOI":"10.1186\/1471-2407-14-132"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154368_bb0120","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/0008-5472.CAN-23-3046","article-title":"MILIP binding to tRNAs promotes protein synthesis to drive triple-negative breast Cancer","volume":"84","author":"Zheng","year":"2024","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154368_bb0125","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.7150\/ijbs.104921","article-title":"FAT1 functions as an oncogenic driver in triple negative breast cancer through AKT pathway-driven effects on the matrisome","volume":"21","author":"Zhao","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0130","doi-asserted-by":"crossref","unstructured":"Li Q, Wang Y, Wu S, Zhou Z, Ding X, Shi R, Thorne RF, Zhang XD, Hu W, Wu M: CircACC1 regulates assembly and activation of AMPK complex under metabolic stress. Cell Metab. 2019, 30(1):157\u2013173.e157.","DOI":"10.1016\/j.cmet.2019.05.009"},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0135","doi-asserted-by":"crossref","unstructured":"Lyu F, Han F, Ge C, Mao W, Chen L, Hu H, Chen G, Lang Q, Fang C: OmicStudio: a composable bioinformatics cloud platform with real-time feedback that can generate high-quality graphs for publication. Imeta 2023, 2(1):e85.","DOI":"10.1002\/imt2.85"},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0140","doi-asserted-by":"crossref","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M: Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013, 495(7441):333.","DOI":"10.1038\/nature11928"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154368_bb0145","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","article-title":"Circular intronic long noncoding RNAs","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154368_bb0150","article-title":"ACSL5 regulates glucose metabolism and chemotherapy sensitivity in colorectal Cancer cells under glutamine deficiency","volume":"13","author":"Tian","year":"2026","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154368_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13316","article-title":"Role of ACSL5 in fatty acid metabolism","volume":"9","author":"Luo","year":"2023","journal-title":"Heliyon"},{"issue":"Pt 5","key":"10.1016\/j.ijbiomac.2026.154368_bb0160","article-title":"Application of stress granule core element G3BP1 in various diseases: a review","volume":"282","author":"Guo","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"5548","key":"10.1016\/j.ijbiomac.2026.154368_bb0165","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.1066015","article-title":"Phosphatidic acid-mediated mitogenic activation of mTOR signaling","volume":"294","author":"Fang","year":"2001","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154368_bb0170","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbalip.2009.02.009","article-title":"Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells","volume":"1791","author":"Foster","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.154368_bb0175","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1074\/jbc.M116.772988","article-title":"Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid","volume":"292","author":"Menon","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0180","doi-asserted-by":"crossref","unstructured":"Yoon M-S, Rosenberger Christina L, Wu C, Truong N, Sweedler Jonathan V, Chen J: Rapid mitogenic regulation of the mTORC1 inhibitor, DEPTOR, by phosphatidic acid. Mol. Cell 2015, 58(3):549\u2013556.","DOI":"10.1016\/j.molcel.2015.03.028"},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2020.06.024","article-title":"Non-coding RNAs, metabolic stress and adaptive mechanisms in cancer","volume":"491","author":"Liu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0190","doi-asserted-by":"crossref","unstructured":"Zhang X, Xu X, Song J, Xu Y, Qian H, Jin J, Liang ZF: Non-coding RNAs' function in cancer development, diagnosis and therapy. Biomed. Pharmacother. 2023, 167:115527.","DOI":"10.1016\/j.biopha.2023.115527"},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2026.154368_bb0195","article-title":"The biological roles of non-coding RNAs in triple-negative breast cancer: therapeutic, diagnostic, drug resistance, and prognostic implications","volume":"328","author":"Pu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.154368_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251810121","article-title":"Circular RNAs: novel players in Cancer mechanisms and therapeutic strategies","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154368_bb0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","article-title":"Circular RNA in cancer","volume":"24","author":"Conn","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0210","doi-asserted-by":"crossref","unstructured":"Lei M, Zheng G, Ning Q, Zheng J, Dong D: Translation and functional roles of circular RNAs in human cancer. Mol. Cancer 2020, 19(1):30.","DOI":"10.1186\/s12943-020-1135-7"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08450-5","article-title":"Circular RNAs in metabolic health: bridging the gap between molecular biology and therapy","volume":"17","author":"Huang","year":"2026","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0220","article-title":"LncRNAs-circRNAs as rising epigenetic binary superstars in regulating lipid metabolic reprogramming of cancers","volume":"11","author":"Liu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.154368_bb0225","article-title":"Advances in the regulation of lipid metabolism by non-coding RNAs","volume":"15","author":"Peng","year":"2025","journal-title":"Animals (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","article-title":"Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets","volume":"33","author":"Gong","year":"2021","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40164-022-00302-0","article-title":"CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p\/LPL axis","volume":"11","author":"Wu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0240","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","article-title":"Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output","volume":"183","author":"Zhao","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1180","article-title":"Lysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long-chain acyl-coenzyme a synthase 5","volume":"13","author":"Zhang","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154368_bb0250","doi-asserted-by":"crossref","DOI":"10.4081\/ejh.2023.3867","article-title":"Regulatory roles of ACSL5 in the anti-tumor function of palmitic acid (C16:0) <em>via<\/em> the ERK signaling pathway","volume":"67","author":"Lv","year":"2023","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0255","doi-asserted-by":"crossref","unstructured":"Martin SD, McGee SL: A systematic flux analysis approach to identify metabolic vulnerabilities in human breast cancer cell lines. Cancer Metab. 2019, 7:12.","DOI":"10.1186\/s40170-019-0207-x"},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.949863","article-title":"ACSL4 as a potential target and biomarker for anticancer: from molecular mechanisms to clinical therapeutics","volume":"13","author":"Hou","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154368_bb0265","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s43556-025-00366-4","article-title":"Long-chain acyl-CoA synthetases: biological functions, diseases and therapeutic targets","volume":"6","author":"Deng","year":"2025","journal-title":"Mol Biomed"},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174397","article-title":"ACSL family: the regulatory mechanisms and therapeutic implications in cancer","volume":"909","author":"Quan","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.858598","article-title":"Circular RNA circLMO1 suppresses cervical Cancer growth and metastasis by triggering miR-4291\/ACSL4-mediated Ferroptosis","volume":"12","author":"Ou","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154368_bb0280","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/15384101.2022.2154543","article-title":"CircSCN8A suppresses malignant progression and induces ferroptosis in non-small cell lung cancer by regulating miR-1290\/ACSL4 axis","volume":"22","author":"Liu","year":"2023","journal-title":"Cell Cycle"},{"issue":"7\u20138","key":"10.1016\/j.ijbiomac.2026.154368_bb0285","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1002\/jcp.29488","article-title":"miR-497-5p mediates starvation-induced death in colon cancer cells by targeting acyl-CoA synthetase-5 and modulation of lipid metabolism","volume":"235","author":"Gharib","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154368_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70643","article-title":"The multifaceted roles of the ACSL family in cancer: metabolic reprogramming, ferroptosis regulation and tumour immune microenvironment remodelling","volume":"16","author":"Li","year":"2026","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0295","doi-asserted-by":"crossref","unstructured":"Perveen S, Ashfaq H, Shahjahan M, Manzoor A, Tayyeb A: Citrullus colocynthis regulates de novo lipid biosynthesis in human breast cancer cells. J. Cancer Res. Ther. 2020, 16(6):1294\u20131301.","DOI":"10.4103\/jcrt.JCRT_206_20"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154368_bb0300","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/ijc.32946","article-title":"ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5","volume":"146","author":"Seo","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.154368_bb0305","doi-asserted-by":"crossref","unstructured":"Zhou Y, Abidi P, Kim A, Chen W, Huang TT, Kraemer FB, Liu J: Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation. Arterioscler. Thromb. Vasc. Biol. 2007, 27(10):2198\u20132205.","DOI":"10.1161\/ATVBAHA.107.148429"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154368_bb0310","article-title":"Systematic analysis of gene expression alterations and clinical outcomes for Long-chain acyl-coenzyme a Synthetase family in Cancer","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154368_bb0315","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s42764-022-00091-0","article-title":"Drops in the cell ocean: new roles for non-coding RNAs in liquid\u2013liquid phase separation","volume":"4","author":"Li","year":"2023","journal-title":"Genome Instability &amp; Disease"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154368_bb0320","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41388-021-02073-0","article-title":"G3BP2 regulated by the lncRNA LINC01554 facilitates esophageal squamous cell carcinoma metastasis through stabilizing HDGF transcript","volume":"41","author":"Zheng","year":"2022","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154368_bb0325","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1073\/pnas.1525387114","article-title":"Stress granule-associated protein G3BP2 regulates breast tumor initiation","volume":"114","author":"Gupta","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302604314X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302604314X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:22:01Z","timestamp":1793917321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302604314X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":65,"alternative-id":["S014181302604314X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154368","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A lipoprotein-responsive circular RNA, circCTCF, couples extracellular lipid availability to mTOR signaling via ACSL5 in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154368"}}